CORT — CORCEPT THERAPEUTICS INC
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1088856 ·
Last close
$123.24
Market Cap
$13.32B
52W High
$124.01
52W Low
$59.03
ADV30
1,165,892
Next earnings
2026-07-29
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 256,147,000 | 252,086,000 | 41,300,000 | 42,987,000 | 888,702,000 | 111,039,000 | 182,926,000 |
| Mar 2026 | 164,903,000 | 162,020,000 | -49,601,000 | -31,761,000 | 814,881,000 | 108,738,000 | 176,894,000 |
| Dec 2025 | 202,125,000 | 199,580,000 | 4,487,000 | 24,288,000 | 836,651,000 | 120,495,000 | 188,846,000 |
| Sep 2025 | 207,638,000 | 203,042,000 | 10,219,000 | 19,668,000 | 823,607,000 | 125,138,000 | 191,705,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$109,700,000
Investing CF
$-21,898,000
Financing CF
$-78,906,000
CapEx
$-2,836,000
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$0.42
As of
2026-08-02
Balance + Analyst (yfinance extras)
Retained Earnings
$654,613,000
Inventory
$13,185,000
Receivables
$76,920,000
ST Investments
$197,158,000
EBIT TTM
$6,405,000
Pretax Income TTM
$26,369,000
Interest Exp TTM
—
Analysts
4
Yahoo Snapshot (yfinance, live)
Total Revenue
$830,812,992
EBITDA
$8,084,000
Free Cash Flow
$77,395,128
Enterprise Value
$13,023,270,912
Total Cash
$308,196,992
Total Debt
$9,421,000
Shares Out
108,098,397
Trailing EPS
$0.46
Book Value
$6.54
ROE
8.2%
ROA
0.5%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 761,407,000 | 44,797,000 | 99,652,000 | 836,651,000 | 188,846,000 | — | 141,996,000 |
| Dec 2024 | 675,040,000 | 136,951,000 | 141,209,000 | 840,553,000 | 160,964,000 | — | 198,295,000 |
| Dec 2023 | 482,375,000 | 107,282,000 | 106,140,000 | 621,517,000 | 114,812,000 | — | 126,681,000 |
| Dec 2022 | 401,858,000 | 112,634,000 | 101,418,000 | 583,430,000 | 81,588,000 | — | 120,323,000 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
$10,102,000
NetIncome TTM
$-4,830,000
OpCashFlow TTM
$0
Assets (Latest)
$51,902,000
Forward EPS
$4.40
Max Pain — expiry 2027-01-15
max pain strike: $82.50 · spot: $123.24 · call oi: 5,100 · put oi: 3,461
Expected Move to 2027-01-15:
±$43.62
(35.39%) —
implied range
$79.62 –
$166.86
· ATM straddle on $125.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| BMRN | BIOMARIN PHARMACEUTICAL INC | $12.60B | $65.07 | — |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | $12.22B | $86.73 | — |
| ELAN | Elanco Animal Health Inc | $12.20B | $24.42 | — |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | $11.83B | $511.97 | — |
| BBIO | BridgeBio Pharma, Inc. | $15.85B | $81.07 | — |
News headlines (Yahoo Finance, 1h cache)
Reflecting On Branded Pharmaceuticals Stocks’ Q2 Earnings: Corcept (NASDAQ:CORT)
2026-08-20 17:15 · Yahoo
Corcept Therapeutics (CORT) Stock May Trade At A Discount Yet A Premium On Sales
2026-08-07 22:11 · Yahoo
Corcept Therapeutics Stock Shines at New All-Time Highs Despite Its Valuation
2026-08-05 14:15 · Yahoo
Corcept Therapeutics Inc (CORT) (Q2 2026) Earnings Call Highlights: Record Revenue and ...
2026-07-30 05:01 · Yahoo
Corcept Therapeutics (CORT) Q2 Earnings and Revenues Surpass Estimates
2026-07-29 22:25 · Yahoo
Corcept (NASDAQ:CORT) Reports Bullish Q2 CY2026, Stock Jumps 17.4%
2026-07-29 20:14 · Yahoo
Spotting Winners: Corcept (NASDAQ:CORT) And Branded Pharmaceuticals Stocks In Q1
2026-07-29 01:57 · Yahoo
Corcept (CORT) Q2 Earnings: What To Expect
2026-07-28 14:21 · Yahoo
Why Corcept (CORT) Stock Is Down Today
2026-07-28 02:05 · Yahoo
Corcept Therapeutics (CORT) Is Up 5.3% After Analysts Lift Full-Year Earnings Outlook Significantly
2026-07-25 05:09 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.